Target Name: UQCC2
NCBI ID: G84300
Other Name(s): M19 | MC3DN7 | Breast cancer associated protein SGA-81M | mitochondrial protein M19 | BA6B20.2 | Ubiquinol-cytochrome-c reductase complex assembly factor 2 | bA6B20.2 | ubiquinol-cytochrome c reductase complex assembly factor 2 | Mitochondrial protein M19 | C6orf126 | breast cancer-associated protein SGA-81M | cytochrome B protein synthesis 6 homolog | Breast cancer-associated protein SGA-81M | mitochondrial nucleoid factor 1 | C6orf125 | OTTHUMP00000016216 | UQCC2_HUMAN | OTTHUMP00000016217 | Cbp6 | MGC14833 | MNF1 | Ubiquinol-cytochrome c reductase complex assembly factor 2

Understanding The Potential of UQCC2 as A Drug Target and Biomarker

UQCC2 (M19) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of inflammation and cellular signaling. UQCC2 has also been shown to interact with several drug targets, making it a potential drug target in its own right.

The protein UQCC2 is composed of 214 amino acids and has a calculated molecular mass of 33.1 kDa. It is located in the endoplasmic reticulum and is expressed in a variety of tissues, including the brain, heart, and kidneys. UQCC2 is known to play a role in the regulation of inflammation and cellular signaling, and it has been shown to interact with several drug targets.

One of the most promising aspects of UQCC2 is its potential as a drug target. The ability of UQCC2 to interact with several drug targets makes it an attractive candidate for drug development. For example, UQCC2 has been shown to interact with several kinases, including Src,FAK, and TrkB. These interactions suggest that UQCC2 may be a useful target for drugs that are designed to inhibit the activity of these kinases.

Another potential mechanism by which UQCC2 may be targeted by drugs is its role in the regulation of inflammation. UQCC2 has been shown to play a role in the regulation of inflammatory responses, and it has been shown to interact with several factors that are involved in inflammation. For example, UQCC2 has been shown to interact with the protein NF-kappa-B, which is involved in the regulation of inflammation. This suggests that UQCC2 may be a useful target for drugs that are designed to inhibit the activity of NF-kappa-B.

In addition to its potential as a drug target, UQCC2 is also of interest as a biomarker. The ability of UQCC2 to interact with several drug targets makes it an attractive candidate for use as a biomarker for drug development. For example, the levels of UQCC2 have been shown to be affected by a variety of factors, including the expression of certain genes and the levels of certain signaling pathways. This suggests that UQCC2 may be a useful biomarker for the diagnosis and evaluation of certain diseases.

Overall, UQCC2 is a protein that has the potential to be a drug target and a biomarker. Further research is needed to fully understand its function and to develop drugs that can specifically target UQCC2. However, the potential of UQCC2 as a drug target and biomarker is an exciting area of research that has the potential to lead to new treatments for a variety of diseases.

Protein Name: Ubiquinol-cytochrome C Reductase Complex Assembly Factor 2

Functions: Required for the assembly of the ubiquinol-cytochrome c reductase complex (mitochondrial respiratory chain complex III or cytochrome b-c1 complex). Plays a role in the modulation of respiratory chain activities such as oxygen consumption and ATP production and via its modulation of the respiratory chain activity can regulate skeletal muscle differentiation and insulin secretion by pancreatic beta-cells. Involved in cytochrome b translation and/or stability

More Common Targets

UQCC3 | UQCC4 | UQCC5 | UQCC6 | UQCR10 | UQCR10P1 | UQCR11 | UQCRB | UQCRBP1 | UQCRC1 | UQCRC2 | UQCRC2P1 | UQCRFS1 | UQCRFS1P1 | UQCRH | UQCRHL | UQCRQ | URAD | URAHP | URB1 | URB1-AS1 | URB2 | Urea transporter | URGCP | URGCP-MRPS24 | URI1 | Uridine phosphorylase | URM1 | UROC1 | UROD | UROS | USB1 | USE1 | USF1 | USF2 | USF3 | USH1C | USH1G | USH2A | USHBP1 | USO1 | USP1 | USP1-UAF1 complex | USP10 | USP11 | USP12 | USP12-AS1 | USP12-DT | USP13 | USP14 | USP15 | USP16 | USP17L1 | USP17L10 | USP17L11 | USP17L12 | USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34